A2 Refereed review article in a scientific journal
What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences
Authors: Rebelos Eleni, Anastasiou Ioanna A., Tentolouris Anastasios, Papanas Nikolaos, Jude Edward
Publisher: Sage
Publication year: 2024
Journal: International Journal of Lower Extremity Wounds
Journal name in source: INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS
Journal acronym: INT J LOW EXTR WOUND
Number of pages: 5
ISSN: 1534-7346
eISSN: 1552-6941
DOI: https://doi.org/10.1177/15347346241233938(external)
Web address : https://journals.sagepub.com/doi/10.1177/15347346241233938(external)
Abstract
Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.
Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.